Zinger Key Points
- Q2 EPS of $3.98 beat estimates; sales dropped 7% to $1.42 billion, missing the $1.50 billion consensus.
- Hawthorne sales plunged 51%; U.S. Consumer sales fell 5% due to a slow season start and fewer one-time items.
- Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who consistently finds profits in volatile markets. Claim your 7-day free trial now.
Scotts Miracle Gro SMG on Wednesday reported second-quarter 2025 adjusted earnings per share of $3.98, up 8%, beating the consensus of $3.95.
The branded consumer lawn and garden product marketer reported sales of $1.42 billion, down 7% year over year, missing the consensus of $1.50 billion.
U.S. Consumer sales decreased 5% to $1.31 billion, resulting from the impact of a colder and slower start to the lawn and garden season, pushing some expected second-quarter sales into the third quarter and non-repeating fiscal 2024 net sales of bulk raw materials and AeroGarden products.
Hawthorne sales fell 51% to $32.7 million.
Also Read: The Week In Cannabis: Delays, Decrees And Deals Reshape The Global Playbook
Q2 GAAP and non-GAAP adjusted gross margins were 38.6% and 39.1%, respectively. These compare to 30.4% and 35.3%, respectively, in the prior year. The improvements were primarily due to lower material, manufacturing, and distribution costs, as well as an improved product and segment mix.
"We continue to advance our fiscal 2025 financial plan focused on sustainable net sales growth, margin recovery and a stronger balance sheet," said Mark Scheiwer, chief financial officer and chief accounting officer. "We are driving significant free cash flow and debt paydown while making incremental investments in consumer activation programs. POS trends have remained consistent through April, and retailer replenishment is expected to be strong in our fiscal third quarter."
Q2 2025 non-GAAP Adjusted EBITDA reached $402.8 million, an improvement of $6.5 million over the prior year.
Guidance: Scotts Miracle Gro reaffirms 2025 guidance and expects low single-digit growth in fiscal 2025 for the U.S. consumer segment.
Given the continued uncertain environment in the cannabis industry, the company is no longer providing full-year revenue guidance for its Hawthorne segment.
"An important underlying story is POS, as for the second straight quarter we drove double-digit increases in consumer takeaway, reflecting the power of our franchise and health of our consumer,” said Jim Hagedorn, chairman and CEO. “This, combined with the fact that we are largely unaffected by tariffs this fiscal year, reaffirms our confidence in our outlook."
The company expects adjusted EBITDA of $570 million to $590 million, with an adjusted gross margin of around 30%.
Price Action: SMG stock was down 13.7% at $46.23 at the last check on Wednesday.
Read Next:
Photo: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!